Bacopa monniera (CDRI-08) Upregulates the Expression of Neuronal and Glial Plasticity Markers in the Brain of Scopolamine Induced Amnesic Mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Konar, Arpita ^a   Gautam, Akash ^b   Thakur, M K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b UNIVERSITY OF HYDERABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ARC PROTEIN; BACOPA MONNIERI EXTRACT; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GLIA; GLIAL PLASTICITY; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCOPOLAMINE-INDUCED AMNESIA; UPREGULATION;

EID: 84941068527     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/837012     Document Type: Article

References (43)

1. S. Dev, "Ancient-modern concordance in ayurvedic plants: Some examples," EnvironmentalHealth Perspectives, vol. 107, no. 10, pp. 783-789, 1999.
2. H. Joshi andM. Parle, "Brahmi rasayana improves learning and memory in mice," Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 79-85, 2006.
3. M. Gallagher, "Animal models of memory impairment," Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 352, no. 1362, pp. 1711-1717, 1997.
4. W. Riedel, E. Hogervorst, F. Verhey, and J. Jolles, "Scopolamine is a model of memory dysfunction, not of aging," European Neuropsychopharmacology, vol. 6, supplement 3, p. 144, 1996.
5. I. Klinkenberg and A. Blokland, "The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies," Neuroscience and Biobehavioral Reviews, vol. 34, no. 8, pp. 1307-1350, 2010.
6. M. K. Saraf, S. Prabhakar, K. L. Khanduja, and A. Anand, "Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 236186, 10 pages, 2011.
7. S. Prabhakar, M. K. Saraf, P. Pandhi, and A. Anand, "Bacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice," Psychopharmacology, vol. 200, no. 1, pp. 27-37, 2008.
8. B. S.McEwen, "Structural plasticity of the adult brain: how animalmodels help us understand brain changes in depression and systemic disorders related to depression," Dialogues in Clinical Neuroscience, vol. 6, no. 2, pp. 119-133, 2004.
9. E. R. Kandel, "The biology ofmemory: a forty-year perspective," The Journal of Neuroscience, vol. 29, no. 41, pp. 12748-12756, 2009.
10. V. P. Nikitin, "A new mechanism of synapse-specific neuronal plasticity," Neuroscience and Behavioral Physiology, vol. 37, no. 6, pp. 559-570, 2007.
11. C. A. McClung and E. J. Nestler, "Neuroplasticity mediated by altered gene expression," Neuropsychopharmacology, vol. 33, no. 1, pp. 3-17, 2008.
12. P. Komulainen, M. Pedersen, T. Hänninen et al., "BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study," Neurobiology of Learning and Memory, vol. 90, no. 4, pp. 596-603, 2008.
13. Y.-H. Hsiao, H.-C. Hung, S.-H. Chen, and P.-W. Gean, "Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis," Journal of Neuroscience, vol. 34, no. 49, pp. 16207-16219, 2014.
14. K. Yamada and T.Nabeshima, "Brain-derived neurotrophic factor/ TrkB signaling inmemory processes," Journal Pharmacological Sciences, vol. 91, no. 4, pp. 267-270, 2003.
15. T. Rantamäki, S. Kemppainen, H. Autio et al., "The impact of BDNF gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease," PLoS ONE, vol. 8, no. 7,Article ID e68722, 2013.
16. B. Y.Wang, Y. Zhong, Z. Zhao, and Y. Miao, "Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils," Pharmacology Biochemistry and Behavior, vol. 126, pp. 83-89, 2014.
17. F. Zheng, Y. Luo, and H.Wang, "Regulation of BDNF-mediated transcription of immediate early gene Arc by intracellular calcium and calmodulin," Journal of Neuroscience Research, vol. 87, no. 2, pp. 380-392, 2009.
18. M. El-Sayed, J. Hofman-Bang, and J. D. Mikkelsen, "Effect of brain-derived neurotrophic factor on activity-regulated cytoskeleton-associated protein gene expression in primary frontal cortical neurons. Comparison with NMDA and AMPA," European Journal of Pharmacology, vol. 660, no. 2-3, pp. 351-357, 2011.
19. Y. Yamasaki, K. Hashikawa, N. Matsuki, andH.Nomura, "Offline Arc transcription in active ensembles during fear memory retrieval," European Journal of Neuroscience, vol. 36, no. 10, pp. 3451-3457, 2012.
20. W. Link, U. W. E. Konietzko, G. Kauselmann et al., "Somatodendritic expression of an immediate early gene is regulated by synaptic activity," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 12, pp. 5734-5738, 1995.
21. G. L. Lyford, K. Yamagata, W. E. Kaufmann et al., "Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites," Neuron, vol. 14, no. 2, pp. 433-445, 1995.
22. M. Terunuma, R. Revilla-Sanchez, I. M. Quadros et al., "Postsynaptic GABAB receptor activity regulates excitatory neuronal architecture and spatial memory,"The Journal of Neuroscience, vol. 34, no. 3, pp. 804-816, 2014.
23. A. Gautam, R. Wadhwa, and M. K. Thakur, "Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leaves," Neurobiology of Learning and Memory, vol. 106, pp. 177-184, 2013.
24. P.Kurosinski, D. Biol, and J. Götz, "Glial cells under physiologic and pathologic conditions," Archives of Neurology, vol. 59,no. 10, pp. 1524-1528, 2002.
25. O. L. Drozdov and V. I. Chorna, "Changes in the content of glial fibrillary acidic protein in the frontal cortex of rats during conditioned active avoidance training," Neurophysiology, vol. 35, no. 2, pp. 98-101, 2003.
26. A. Konar, N. Shah, R. Singh et al., "Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells," PLoS ONE, vol. 6, no. 11, Article ID e27265, 2011.
27. G. L. Ellman, K. D. Courtney,V. Andres Jr., and R. M. Featherstone, "A new and rapid colorimetric determination of acetylcholinesterase activity," Biochemical Pharmacology, vol. 7, no. 2, pp. 88-95, 1961.
28. H. K. Singh, "Brain enhancing ingredients from ayurvedic medicine: quintessential example of Bacopa monniera, a narrative review," Nutrients, vol. 5, no. 2, pp. 478-497, 2013.
29. H. Soreq and S. Seidman, "Acetylcholinesterase - new roles for an old actor,"Nature ReviewsNeuroscience, vol. 2, no.4,pp. 294-302, 2001.
30. G. Sberna, J. Sáez-Valero, Q.-X. Li et al., "Acetylcholinesterase is increased in the brains of transgenic mice expressing the Cterminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease," Journal of Neurochemistry, vol. 71, no. 2, pp. 723-731, 1998.
31. A.Das, G. Shanker, C.Nath, R. Pal, S. Singh, and H. K. Singh, "A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba - anticholinesterase and cognitive enhancing activities," Pharmacology Biochemistry and Behavior, vol. 73, no. 4, pp. 893-900, 2002.
32. A. E.West,W. G. Chen, M. B. Dalva et al., "Calcium regulation of neuronal gene expression," Proceedings of theNational Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11024-11031, 2001.
33. O. Arancio and M. V. Chao, "Neurotrophins, synaptic plasticity and dementia," Current Opinion in Neurobiology, vol. 17, no. 3, pp. 325-330, 2007.
34. J. Preethi, H. K. Singh, J. S. Venkataraman, and K. E. Rajan, "Standardised extract of Bacopa monniera (CDRI-08) improves contextual fear memory by differentially regulating the activity of histone acetylation and protein phosphatases (PP1α, PP2A) in hippocampus," Cellular and Molecular Neurobiology, vol. 34, no. 4, pp. 577-589, 2014.
35. J. D. Shepherd and M. F. Bear, "New views of Arc, a master regulator of synaptic plasticity," Nature Neuroscience, vol. 14, no. 3, pp. 279-284, 2011.
36. A. M. Mabb, H. S. Je, M. J. Wall et al., "Triad3A regulates synaptic strength by ubiquitination of arc," Neuron, vol. 82, no. 6, pp. 1299-1316, 2014.
37. A. V. Tzingounis and R. A. Nicoll, "Arc/Arg3.1: linking gene expression to synaptic plasticity and memory," Neuron, vol. 52, no. 3, pp. 403-407, 2006.
38. C. R. Bramham and E. Messaoudi, "BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis," Progress in Neurobiology, vol. 76, no. 2, pp. 99-125, 2005.
39. G. Leal, D. Comprido, and C. B.Duarte, "BDNF-induced local protein synthesis and synaptic plasticity," Neuropharmacology, vol. 76, no. C, pp. 639-656, 2014.
40. C. Robinet and L. Pellerin, "Brain-derived neurotrophic factor enhances the hippocampal expression of key postsynaptic proteins in vivo including the monocarboxylate transporter MCT2," Neuroscience, vol. 192, pp. 155-163, 2011.
41. O. Pascual, S. B. Achour, P. Rostaing, A. Triller, and A. Bessis, "Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 4, pp. E197-E205, 2012.
42. E. C. Phillips, C. L. Croft, K. Kurbatskaya et al., "Astrocytes and neuroinflammation in Alzheimer's disease," Biochemical Society Transactions, vol. 42, no. 5, pp. 1321-1325, 2014.
43. W.Cho, M. Brenner,N. Peters, and A.Messing, "Drug screening to identify suppressors of GFAP expression," Human Molecular Genetics, vol. 19, no. 16, pp. 3169-3178, 2010.